Table 2 Morbidity and mortality of the study group according to the presence of end-stage renal disease
From: End-stage renal disease and outcome in a surgical intensive care unit
All patients | ESRD | No ESRD | P value | |
|---|---|---|---|---|
(n = 12,938) | (n = 199) | (n = 12,739) | ||
Organ failure, n (%) | ||||
- On admission to the ICU | ||||
Cardiovascular | 5,974 (46.2) | 135 (67.8) | 5,839 (45.8) | <0.001 |
CNS | 4,747 (36.7) | 90 (45.2) | 4,657 (36.6) | 0.012 |
Respiratory | 3,120 (24.1) | 68 (34.2) | 3,052 (24.0) | 0.001 |
Renal | 390 (3.0) | 199 (100) | 237 (1.9) | <0.001 |
Hematologic | 309 (2.4) | 27 (13.6) | 282 (2.2) | <0.001 |
Hepatic | 215 (1.7) | 15 (7.5) | 200 (1.6) | <0.001 |
- At any time during ICU stay | ||||
Cardiovascular | 6,407 (49.5) | 144 (72.4) | 6,263 (49.2) | <0.001 |
CNS | 5,489 (42.4) | 112 (56.3) | 5,377 (42.2) | <0.001 |
Respiratory | 3,992 (30.9) | 88 (44.2) | 3,904 (30.6) | <0.001 |
Renal | 630 (4.9) | 199 (100) | 431 (3.4) | <0.001 |
Hematologic | 618 (4.8) | 43 (21.6) | 575 (4.5) | <0.001 |
Hepatic | 405 (3.1) | 24 (12.1) | 381 (3.0) | <0.001 |
SOFAmax scores, mean ± SD | ||||
SOFAmax | 6.5 ± 4.3 | 11.5 ± 4.6 | 6.4 ± 4.2 | <0.001 |
SOFAmax without renal points | 5.7 ± 3.6 | 7.5 ± 4.2 | 5.6 ± 3.6 | <0.001 |
ICU mortality, n (%) | 746 (5.8) | 46 (23.1) | 700 (5.5) | <0.001 |
Hospital mortality, n (%) | 1,330 (10.3) | 62 (31.2) | 1,268 (10.0) | <0.001 |
ICU LOS in days, median (IQR) | 1 (1–3) | 2 (1–7) | 1 (1–3) | <0.001 |